Results 151 to 160 of about 10,379 (219)

Factors and barriers to sulfadoxine-pyrimethamine uptake for intermittent preventive treatment during pregnancy in Ghana

Richmond Bediako Nsiah, Akua Kumi Yeboah, Patrick Ohemeng Gyaase, Regina Amoa-Tutu, Abdul-Rahman Zakaria, Lynna Naa Adede Obeng, Frank Prempeh, P. Opoku, Amos Andoono, Gilbert Dagoe, Kwame Kusi Agyemang, Jonathan Mawutor Gmanyami, Dominic Nyarko, Gifty Sefaah Owusu, Solomon Anum-Doku, Solomon Anum-Doku   +15 more
openalex   +1 more source

Frequencies of molecular markers of drug resistance in the context of two different Seasonal Malaria Chemoprevention (SMC) treatment regimens in the Koulikoro health district, Mali. [PDF]

Antimicrob Agents Chemother
Traore B, Kane F, Toure M, Jørgensen MHM, Sanogo D, Keita S, Keita M, Sogoba N, Shaw-Saliba K, Diakite M, Shaffer JG, Alifrangis M, Hansson H, Doumbia S.   +13 more
europepmc   +1 more source

Prevalence of asymptomatic malaria and associated factors among pregnant women in Mogadishu, Somalia: a cross-sectional study. [PDF]

Malar J
Abdi MY, Mohamud FA, Abdullahi SA.
europepmc   +1 more source

Effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on maternal gestational weight gain in low-income and middle-income countries: a systematic review and individual participant data meta-analysis of randomised clinical trials. [PDF]

EClinicalMedicine
Liu E, Partap U, Shinde S, Wang D, Costa JC, Cliffer IR, Wang M, Nookala SK, Subramoney V, Briggs B, Hamer DH, Akurut H, Argaw A, Ashorn U, Chinkhumba J, Desai M, Divala TH, Elliott AM, Gutman JR, Hien A, Huybregts L, Kajubi R, Kakuru A, Kariuki S, Lachat C, Laufer MK, Luntamo M, Maleta K, Mathanga DP, Ochieng T, Ome-Kaius M, Patson N, Roberfroid D, Rogerson SJ, Toe LC, Unger HW, Webb EL, Fawzi WW.   +37 more
europepmc   +1 more source

Pharmacometric evaluation of amodiaquine-sulfadoxine-pyrimethamine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda

Bonnington C, Nuwa A, Theiss-Nyland K, Kajubi R, Kamya MR, Nankabirwa J, Ebong C, Rassi C, Nabakooza J, Opigo J, Salandindi D, Odongo M, Sararat C, Watson JA, Suwannasin K, Proux S, Koesukwiwat U, Tarning J, Imwong M, Tibenderana J, Nosten F, White N.   +21 more
europepmc   +1 more source

Comprehensive genomic study of Plasmodium falciparum in Sierra leone: genetic variation and resistance patterns. [PDF]

BMC Genomics
Zhan XJ, Chen SB, Wang TY, Duan YW, Shen HM, Chen JH, Xie JJ.   +6 more
europepmc   +1 more source

Changes in the Prevalence of Antimalarial Partner Drug Resistance Markers and Policy in 6 Sub-Saharan African Countries From 2000 to 2021: A Systematic Review. [PDF]

Open Forum Infect Dis
Walker A, Ross A, Nsanzabana C.
europepmc   +1 more source

Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial.

Lancet Infect Dis
Idro R, Nkosi-Gondwe T, Opoka R, Ssenkusu JM, Dennis K, Tsirizani L, Akun P, Rujumba J, Nambatya W, Kamya C, Phiri N, Joanita K, Komata R, Innussa M, Tenywa E, John CC, Tarning J, Denti P, Wasmann RE, Ter Kuile FO, Robberstad B, Phiri KS.   +21 more
europepmc   +1 more source

Genotypic analysis of Plasmodium falciparum malaria parasites in a clinical trial of RTS,S vaccination in combination with seasonal malaria chemoprevention

LaVerriere E, Kelley K, Dicko A, Sagara I, Mahamar A, Ouedraogo J, Zongo I, Tinto H, Chandramohan D, Greenwood B, Neafsey DE.   +10 more
europepmc   +1 more source